NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
A new treatment for Parkinson’s disease has recently been made available in Ireland...
In this issue, highlights from the major national and international 2023 Annual Scientific Meetings in neurology...
Neurological disorders are currently the second highest cause of death and the leading cause of disability...
A ground-breaking discovery into the mechanisms driving Rett syndrome was unveiled during the 2023 World Congress...
During a plenary lecture at the World Congress of Neurology, Prof Anthony Lang, Professor of Neurology...
ECTRIMS 2023 heard how growing understanding of the pathology and underlying mechanisms of MS...
An overview of the key changes in the National Clinical Guideline for Stroke for the UK...
The largest genetic study of epilepsy to date provides new insights on why epilepsy develops and...
New daily persistent headache (NDPH) is a not uncommon form of chronic daily headache (CDH)...
Migraine. Once you have distinguished a migraine from a ‘regular’ headache, it helps the...
Idiopathic Parkinson's disease (IPD) is a common, progressive, neurodegenerative disease, which...
The overall prognosis for people with newly-diagnosed epilepsy is good, with 60−70 per cent becoming...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT